I uncover a high-quality dividend growth stock that appears to be undervalued each week for Daily Trade Alert, which is a site that focuses on dividend growth investing, stocks, and unique investment opportunities. I’ve been writing for them for years now, and they’re just great over there. Each week, I publish an excerpt of my work, when it’s fresh off the press. That way, you readers are given the opportunity to check it out. The content is totally free. I hope you enjoy!
It’s amazing how straightforward building real and lasting wealth and passive income can be.
Society had me tricked for so long, having me believe that it was some kind of fairy tale reserved for the lucky and/or powerful few that kept all the secrets to themselves.
But there’s no secret at all.
However, there’s some hard work involved, which is quite possibly enough to turn away a lot of people.
Nonetheless, if you’re willing to work hard, live below your means, and invest your capital intelligently, financial freedom can be yours.
Image courtesy of: Stuart Miles at FreeDigitalPhotos.net.
Thanks Jason, continue to like these posts.
Like you I own 40 shares of Abbvie. They have proven to be a steady dividend payer with good growth at an already above average level.
Cheers,
Tall Investing
TI,
Tough to dislike AbbVie. You’re getting above-average yield and growth at a below-average valuation. I think the latter exists because of the reliance on one product, which is a significant risk. Nonetheless, it’s a high-quality business that is doing incredibly well. Moreover, one should diversify appropriately so as to mitigate that risk.
Thanks for stopping by!
Best regards.
Agreed. Tough to dislike ABBV. It’s one of my larger positions and has been with me since the ABT spin off. It’s a keeper for the foreseeable future.
Keith,
A keeper, indeed. Have no plans to offload this one. 🙂
Cheers.
I like ABBV. I am full position in my portfolio with this company. Thanks for the review of this company.
FV,
Glad to be a fellow shareholder. We should continue to do well over the long haul.
Best wishes!
ABBV is one of the first international stocks I have ever considered. Great post.
BHL,
Thanks. Glad you enjoyed it!
Cheers.
Hi Jason
A great article on ABBV Jason. No doubt a great company and dividend payer. I agree with what you wrote on ABBV, and ABBV has done a great job in creating share holders value. I am long ABBV and have 193 shares and if it pulls back some would love to add to my position.
Cheers
Michael,
Happy to be a fellow shareholder. It’s a great company. The reliance on Humira is a key risk, but the valuation seems to be pricing much of that in. Meanwhile, you’re getting paid a healthy dividend while they diversify the business. Tough to not like that.
Thanks for dropping by!
Best wishes.
Love this pick and it’s definitely on my radar as well. I just bought 100 shares each of KO and XOM and added 86 to my VIG position so I’m waiting to stock back up to pick up a few shares myself. Thanks for the great write up.
DD,
Hey, I’m happy to share these ideas. S&P Capital IQ looks a little aggressive with their FV, but the stock still appears to be one of the more compelling dividend growth stocks available when considering the valuation, growth, and yield. 🙂
Best regards!
I agree ABBV is a good company. I picked up 100 shares three months back when it was at $60.60, and remain a happy shareholder. Looking for some diversification of the product line.
-Mike
Mike,
Agreed. They need to continue to build out, but I think the valuation, in part, reflects that need. Nonetheless, the growth and yield combine to make a pretty compelling case. 🙂
Cheers!